| Stage | URI | % of rev | UTI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $4.9B | 100.00% | $219M | 100.00% | URI ×22.35 |
| Gross profit | $2.0B | 41.81% | $219M | 100.00% | UTI +58.2pp |
| Operating income | $1.4B | 28.80% | $3M | 1.48% | URI +27.3pp |
| Pre-tax income | $1.2B | 25.16% | $3M | 1.42% | URI +23.7pp |
| Net income | $920M | 18.80% | $2M | 1.04% | URI +17.8pp |
| Stage | URI | UTI | Gap · A − B |
|---|---|---|---|
| Revenue | $4.9B100.00% | $219M100.00% | URI ×22.35 |
| Gross profit | 41.81%$2.0B | 100.00%$219M | UTI +58.2pp |
| Operating income | 28.80%$1.4B | 1.48%$3M | URI +27.3pp |
| Pre-tax income | 25.16%$1.2B | 1.42%$3M | URI +23.7pp |
| Net income |
| 18.80%$920M |
| 1.04%$2M |
| URI +17.8pp |
None
No disclosed counterparties: URI.